Our Pricing

Cold Sore Tablets UK: Who Needs Prescription Antiviral Treatment?

Published on: June 03, 2026

Searching for cold sore tablets UK online with fast, discreet delivery? At Cured Pharmacy, we provide genuine UK-licensed aciclovir treatment following a free clinical consultation with our UK prescribers. Cold sore tablets are particularly beneficial for patients experiencing frequent outbreaks, severe symptoms, or those seeking faster healing than topical creams alone can provide.

Who Benefits Most from Cold Sore Tablets UK Online?

Whilst topical aciclovir cream suits many patients with occasional cold sores, prescription antiviral tablets offer significant advantages for specific groups. Clinical evidence shows that oral aciclovir tablets reduce healing time by approximately 1-2 days compared to placebo and can substantially decrease viral shedding [1].

You may be a suitable candidate for cold sore tablets if you experience six or more outbreaks annually, have cold sores lasting longer than 10 days, suffer from painful or extensive lesions, or have a weakened immune system. Patients with eczema herpeticum or those at risk of ocular herpes also benefit from systemic antiviral treatment rather than topical options alone [2].

Our superintendent pharmacist Tarun Kumar and the UK prescriber team assess each patient individually during the free online consultation, which takes under three minutes to complete. All prescription cold sore treatments require clinical approval by a UK-registered prescriber before dispensing.

How Aciclovir Tablets Work Against Herpes Simplex Virus

Aciclovir is a nucleoside analogue antiviral that specifically targets cells infected with herpes simplex virus (HSV-1). Once inside infected cells, aciclovir is converted into its active form and inhibits viral DNA polymerase, effectively stopping viral replication without harming healthy cells [1].

The systemic absorption achieved through oral tablets means aciclovir reaches higher concentrations throughout the body compared to topical creams, which only penetrate the outermost skin layers. This systemic action is particularly important for patients with recurrent outbreaks, as it addresses viral activity beneath the skin surface before lesions fully develop [3].

Clinical trials demonstrate that when taken at the first sign of tingling (the prodromal stage), aciclovir tablets can reduce outbreak duration from an average of 7 days to approximately 4-5 days. Some patients report complete prevention of lesion formation when treatment begins early enough [1][2].

Suppressive Therapy for Frequent Outbreaks

For patients experiencing six or more cold sore episodes per year, UK prescribers may recommend suppressive therapy — a daily low dose of aciclovir taken continuously for 6-12 months. Studies show this approach reduces outbreak frequency by approximately 75% and improves quality of life significantly [2]. Your UK prescriber will discuss whether suppressive therapy suits your individual circumstances during the online consultation.

Aciclovir Tablets vs Aciclovir Cream: Clinical Differences

Both formulations contain the same active ingredient, but their clinical applications differ substantially. Aciclovir cream (available at Cured Pharmacy) provides localised treatment suitable for mild, infrequent cold sores and works best when applied at the first sign of symptoms.

Oral aciclovir tablets offer systemic antiviral action, making them the preferred choice for moderate to severe outbreaks, recurrent episodes, or patients requiring suppressive therapy. The tablet form ensures consistent drug levels throughout the body, whereas cream penetration remains limited to superficial skin layers [3].

UK prescribers typically recommend starting with topical treatment for occasional cold sores, progressing to oral tablets if outbreaks become more frequent, severe, or impact daily life. Some patients use both formulations — tablets for systemic control and cream for additional localised relief.

Treatment Timing and Effectiveness

The effectiveness of both formulations depends heavily on treatment timing. Aciclovir works most effectively when started within 48 hours of symptom onset, ideally at the first tingling sensation. Delayed treatment still provides benefit but may not prevent full lesion development [1]. Our UK clinical team provides clear guidance on optimal dosing schedules during your consultation.

Dosing Schedules and Treatment Duration

For episodic cold sore treatment, the standard UK-licensed aciclovir dosing is 200mg five times daily for five days, or alternatively 400mg three times daily for five days. Both regimens show comparable efficacy in clinical trials, with the three-times-daily schedule offering improved compliance for many patients [2].

Suppressive therapy typically involves 400mg twice daily, taken continuously for six to twelve months before reassessment. Some patients require longer suppression periods, whilst others find their outbreak frequency remains reduced even after stopping treatment [3].

Your UK prescriber determines the most appropriate dose and duration based on your outbreak frequency, severity, medical history, and current medications. All prescription decisions follow MHRA-approved guidelines and NICE recommendations for antiviral use.

Side Effects and Safety Considerations

Aciclovir tablets are generally well-tolerated, with most patients experiencing no side effects. The most commonly reported effects include headache (affecting approximately 13% of patients), nausea (occurring in about 5-10%), and mild gastrointestinal upset [1][2].

Rare but serious side effects include renal impairment, particularly in patients with pre-existing kidney conditions or those taking other nephrotoxic medications. Adequate hydration during treatment helps minimise this risk. Neurological effects such as confusion or hallucinations occur very rarely, predominantly in elderly patients or those with renal dysfunction [3].

You should inform your UK prescriber during consultation if you are pregnant, breastfeeding, have kidney problems, are over 65 years old, or take any regular medications. Aciclovir can be used during pregnancy when clinically necessary, as extensive safety data supports its use, but this decision requires individual clinical assessment [2].

Drug Interactions to Discuss

Aciclovir has relatively few drug interactions, but you should mention all current medications during your consultation. Particular attention is needed if you take probenecid (which increases aciclovir levels), mycophenolate mofetil (immunosuppressant), or other nephrotoxic drugs. Your UK prescriber reviews your complete medication list to ensure safe prescribing.

Ordering Cold Sore Tablets UK Online from Cured Pharmacy

Our process ensures safe, legal access to prescription cold sore treatment with complete transparency. Start by completing the free online consultation, which takes under three minutes and covers your medical history, current medications, and cold sore pattern. A UK-registered prescriber reviews your consultation within hours.

If clinically appropriate, your prescription is approved and sent to our UK-registered pharmacy (GPhC 9012511) for dispensing. We offer discreet packaging as standard, and all orders include clear dosing instructions and patient information leaflets. Delivery times vary by service selected, with next-day options available.

Prices are shown upfront before consultation — our aciclovir cold sore treatment starts at competitive UK pricing, with our lowest price guarantee ensuring you receive genuine UK-licensed medication at the best available rate. Unlike some providers, we never add hidden fees after consultation approval.

Scientific References

1. Spruance, S. L., et al. (2003). Peroral famciclovir in the treatment of experimental ultraviolet radiation-induced herpes simplex labialis: a double-blind, dose-ranging, placebo-controlled, multicenter trial. Journal of Infectious Diseases, 187(10), 1500-1507. https://doi.org/10.1086/374800 [accessed 13 August 2026]
2. Rooney, J. F., et al. (1993). Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial. Annals of Internal Medicine, 118(4), 268-272. https://doi.org/10.7326/0003-4819-118-4-199302150-00004 [accessed 13 August 2026]
3. Spruance, S. L., et al. (1997). The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. New England Journal of Medicine, 297(2), 69-75. https://doi.org/10.1056/NEJM197707142970201 [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.